ACSS2 modulates endothelial glycolysis in angiogenesis
Proceedings of the National Academy of Sciences · 24.11.2026 · 123 (47)
DOI: 10.1073/pnas.2528240123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.11.2026. Verfasst von Yunyun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China. Hauptthemen laut MEDLINE: Glycolysis, Acetate-CoA Ligase, Neovascularization, Pathologic, Angiogenesis. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), HHS | NIH (NIH).
Abstract (Originalsprache)
Endothelial cells (ECs) sustain high glycolytic flux and display remarkable metabolic plasticity. Although molecular pathways regulating endothelial glycolysis are well characterized, metabolic mechanisms underlying hypoxia-induced glycolytic activation during angiogenesis remain poorly understood. Here, we show that acetyl-CoA synthetase 2 (ACSS2) serves as a critical metabolic modulator, coupling acetate utilization with glycolytic flux to control EC function and angiogenesis. The high level of ACSS2-mediated acetate-to-acetyl-CoA conversion in angiogenic front ECs sustains acetyl-CoA levels, which are essential for EC proliferation and retinal vascularization. Conversely, endothelial-specific Acss2 deletion disrupts pathological angiogenesis and normalizes tumor vasculature. Mechanistically, ACSS2 maintains hypoxia-inducible factor 1α transcriptional activity and stabilizes glucose transporter 1, thereby preserving glycolysis. Pyruvate dehydrogenase kinase 4 knockdown rescues metabolic and functional defects in ACSS2-deficient ECs, revealing the vital role of acetyl-CoA homeostasis in modulating hypoxic endothelial metabolism. Taken together, these data establish ACSS2 as a pivotal regulator of vascular development and suggest that targeting acetate metabolism may be an effective way to modulate pathological angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- Yale University School of Medicine, New Haven, CT 06520.
- School of Life Sciences, Xiamen University, Xiamen 361102, China.
- Core Facility of Biomedical Sciences, Xiamen University, Xiamen 361102, China.
ORCID-Profile: Yunyun Wang, Qingqiao Zha, Rong-Mo Zhang, Hong Chen, He Cai, Jingyi Xiang, Lei Zhang, Michael Simons, Luyang Yu, Xiaolong Zhu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- HHS | NIH (NIH)
Zitieren
APA
Wang, Y., Zha, Q., Zhang, R. M., Chen, H., Cai, H., Xiang, J., Kou, Y., Qiu, C., Zhang, L., Simons, M., Yu, L., & Zhu, X. (2026). ACSS2 modulates endothelial glycolysis in angiogenesis. Proceedings of the National Academy of Sciences, 123(47). https://doi.org/10.1073/pnas.2528240123
Vancouver
Wang Y, Zha Q, Zhang RM, Chen H, Cai H, Xiang J, et al. ACSS2 modulates endothelial glycolysis in angiogenesis. Proceedings of the National Academy of Sciences. 2026;123(47). doi:10.1073/pnas.2528240123
BibTeX
@article{Wang2026,
author = {Wang, Yunyun and Zha, Qingqiao and Zhang, Rong-Mo and Chen, Hong and Cai, He and Xiang, Jingyi and Kou, Yaohui and Qiu, Cong and Zhang, Lei and Simons, Michael and Yu, Luyang and Zhu, Xiaolong},
title = {ACSS2 modulates endothelial glycolysis in angiogenesis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {47},
doi = {10.1073/pnas.2528240123}
}
EUVIMED